Home>Topics>Companies>McKesson

McKesson MCK

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
    1. From Barron’s, September 22, 2014 (Part 2)

      Commentary

      Sat, 20 Sep 2014

      sensor-hub and Apple Pay functions; pg 30]; Vitamin Shoppe [ VSI ; pg 39]; drug and healthcare supplies distributor McKesson [ MCK ; CEO spotlight on John Hammergren ; pg 40]. GNW story http://online.barrons.com/news/articles/SB52133021052493823286804580158270334723144

    2. Cramer's Mad Money - Fascinating Schisms (9/2/14)

      Headlines

      Wed, 3 Sep 2014

      NYSE: KR ), Macy's (NYSE: M ), Tenet (NYSE: THC ), HCA (NYSE: HCA ), CVS Caremark (NYSE: CVS ), McKesson (NYSE: MCK ), Perrigo (NYSE: PRGO ), Mallinckrodt (NYSE: MNK ), Regeneron (NASDAQ: REGN ), Gilead (NASDAQ: GILD

    3. New Morningstar Analyst Report for McKesson Corp

      Stock Reports

      Mon, 25 Aug 2014

      Profit margins for McKesson are razor thin, making any significant ..... cheaper supply of generic product, McKesson has acquired a major European drug distributor ..... to a direct drug distribution model, McKesson 's results could be negatively affected

    4. Don’t Ignore Higher Taxes Until Tax Day

      Headlines

      Mon, 18 Aug 2014

      The company is one of the smallest players in the medical distribution field, which is dominated by giants such as McKesson MCK and Cardinal Health CAH. Yet it has persistently increased its market share within the small niche it occupies (the

    5. UPDATE 1- McKesson pays $18 mln in temperature monitor false claims case

      Headlines

      Fri, 8 Aug 2014

      Aug 8 (Reuters) - McKesson Corp agreed to pay $18 million to settle U.S. charges that it violated its contract with the U.S. Centers for Disease Control and Prevention by falsely assuring that it had been shipping vaccines at the correct temperature.

    6. McKesson pays $18 mln in temperature monitor false claims case

      Headlines

      Fri, 8 Aug 2014

      Aug 8 (Reuters) - McKesson Corp agreed to pay $18 million to settle U.S. charges that it violated its contract with the Centers for Disease Control and Prevention by falsely assuring that it had been shipping vaccines at the correct temperature.

    7. McKesson Reports In-Line First Quarter as Celesio Buoys the Firm's Results

      Commentary

      Thu, 31 Jul 2014

      McKesson reported results for its fiscal first quarter ..... 177 fair value estimate. Helping to boost McKesson 's operations was the recent Celesio acquisition ..... a positive strategic move that enhances McKesson ’s supplier purchasing power and solidifies

    8. Credit Market Outlook: Tight Spreads Will Keep a Lid on Returns

      Headlines

      Thu, 26 Jun 2014

      the first half of 2014, we downgraded Actavis ACT "> ACT , Bayer BAYRY "> BAYRY , Mallinckrodt MNK "> MNK , McKesson MCK "> MCK , Novartis NVS "> NVS , and Zimmer ZMH "> ZMH because of these events. Also, in early 2014, Baxter BAX

    9. UPDATE 1-Hedge fund sues McKesson for $500 mln over Celesio deal

      Headlines

      Wed, 21 May 2014

      * Magnetar says minority Celesio shareholders short changed

    10. After Our Review, We Believe McKesson ’s Recent Acquisition of Celesio Will Strengthen Its Operations

      Commentary

      Mon, 19 May 2014

      We believe McKesson ’s recent acquisition of major European ..... distribution advantages should benefit McKesson operationally. The firm will have the ..... Additionally, by acquiring Celesio, McKesson cements its status as the premier global

    « Prev12345Next »
    Content Partners